DEBRA SCHROER: Open Payments
NPI 1295846798 · SANTA CLAUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 18 payments from 9 companies in 2025. Trend: 2023 $338 · 2024 $473 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $193 |
| ABBVIE INC. | 3 | $55 |
| Lilly USA, LLC | 2 | $37 |
| PFIZER INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Wegovy, Ozempic, MOUNJARO, TRELEGY ELLIPTA, UBRELVY, QULIPTA, Auvelity, VRAYLAR.
Industry payments across IN — which companies pay providers there.
